Life Extension Magazine

Life Extension Magazine May 2002

Cover Story

Page 3 of 3

References for "Does Vitamin E Prevent Breast Cancer?"

1. Lifetime Probability of Breast Cancer in American Women. Cancer Facts. National Cancer Institute

2. Schwenke D.C. Does lack of tocopherols and tocotriemols put women at increased risk of breast cancer? Journal of Nutritional Biochemistry 13 (2002) 2-20.

3. Mannisto S., et al. Diet and risk of breast cancer in a case-control study: does the threat of disease have on influence on recall bias? J. Clin. Epidemiol. 52 (1999) 429-439.

4. Bohike K., et al. Vitamins A, C and E and the risk of breast cancer: results from a case-control study in Greece. Br. J. Cancer 79 (1999) 23-29.

5. Ambrosone C.B., et al. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk. (New York, United States), Cancer Causes & Control 6 (1995) 407-415.

6. Ronco A., et al. Vegetables, fruits and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutrition & Metabolism 35 (1999) 111-119.

7. Freudenheim J.L., et al. Premenopausal breast cancer risk and intake of vegetables, fruits and related nutrients. J. Natl. Cancer Inst. 88 (1996) 340-348.

8. Mezzetti M., et al. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J. Natl. Cancer Inst. 90 (1998) 389-394.

9. Richardson S., et al. The role of fat, animal protein and some vitamin consumprtion in breast cancer: a case control study in southern France. Int. J. Cancer 48 (1991) 1-9.

10. Wu D, et al. In vitro supplementation with different tocopherol homologues can affect the function of immune cells in old mice. Free Radic Biol Med 2000 Feb 15;28(4):643-51.

11. Zhong S., et al. Dietary crotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 91 (1999) 547-556.

12. Rohan T.E., et al. Dietary fiber, vitamins A, C and E, and risk of breast cancer: a cohort study. Cancer Causes & Control 4 (1993) 29-37.

13. Hunter D.J., et al. A prospective study of the intake of vitamin-C, vitamin-E, and vitamin-A and the risk of breast cancer. New Engl. J. Med. 329 (1993) 234-240.

14. Kushi L.H., et al. Intake of vitamins A, C and E, and postmenopausal breast cancer - The Iowa Women's Health Study. Am. J. Epidemiol. 144 (1996) 165-174.

15. Shibata A., et al. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly-a prospective study. Br. J. Cancer. 66 (1992) 673-679.

16. London S.J., et al. Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes & Control 3 (1992) 503-512.

17. Comstock G.W., et al. Prediagnostic serum levels of carotenoids and vitamin-E as related to subsequent cancer in Washington County, Maryland. Am. J. Clin. Nutr. 53 (1991) S260-S264.

18. Dorgan J.F., et al. Relationship of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes & Control 9 (1998) 89-97.

19. Chajes V., et al. Alpha-tocopherol and hydroperoxide content in breast adipose tissue from patients with breast tumours. Int. J. Cancer 67 (1996) 170-175.

20. Zhu Z., et al. Vitamin E concentration in breast adipose tissue of breast cancer patients (Kupio, Finland). Cancer Causes & Control 7 (1996) 591-595.

21. van't Veer P, et al. Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidant, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidem. Biomarkers Prevent. 5 (1996) 441-447.

22. Charpentier A, et al. RRR-alpha-Tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells. Nutr. Cancer (USA) , 1993, 19/3 (225-239).

23. Zhao B, et al. Involvement of activator protein-1 (AP-1) in induction of apoptosis by Vitamin E succinate in human breast cancer cells. Molecular Carcinogenesis (USA), 1997, 19/3 (180-190).

24. Turley J.M.; et al. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclin a negatively regulates E2F transactivation activity. Cancer Research (USA), 1997, 57/13 (2668-2675).

25. Turley J.M.; et al. Vitamin E succinate induces fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Research (USA) , 1997, 57/5 (881-890).

26. Djuric Z, et al. Growth inhibition of MCF-7 and MCF-10A human-breast cells by alpha-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs. Cancer Letters (Ireland), 1997, 111/1-2 (133-139).

27. Charpentier A, et al. RRR-alpha-tocopheryl succinate enhances TGF-beta1, -beta2, and -beta3 and TGF- betaR-II expression by human MDA-MB-435 breast cancer cells. Nutrition and Cancer (USA) , 1996, 26/2 (237-250).

28. You H, et al. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ 2001 Sep;12(9):471-80.

29. Yu W, et al. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res 2001 Sep 1;61(17):6569-76.

30. Malafa MP, et al. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000 Sep;93(1):163-70.

31. Heisler T, et al. Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells. J Surg Res 2000 Jun 1;91(1):9-14.

32. Tesarik J, et al. Estradiol modulates breast cancer cell apoptosis: a novel nongenomic steroid action relevant to carcinogenesis. Steroids 1999 Jan-Feb;64(1-2):22-7.

33. Yu W, et al. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res 1999 Feb 15;59(4):953-61.

34. Yu W, et al. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol Carcinog 1998 Aug;22(4):247-57.

35. Yu W, et al. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer 1997;27(3):267-78.

36. Nesaretnam, K. et al. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33 (1998) 461-469.

37. Gunthrie N., et al. Inhibition of proliferation of estrogen receptor- negative MDA-MB-435 and positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127 (1997) S544-S548.

38. Nesaretnam K., et al. Tocotrienols inhibit growth of ZR-75-J breast cancer cells. Int. J. Food Sci. Nutr. 51 (Suppl) (200) S95-S103.

39. Nesaretnam K., et al. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30 (1995) 1139-1143.

40. Gundimeda U., et al. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J. Biol. Chem. 271 (1996) 13504-13514.

41. Sigournas G., et al. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer 28 (1997) 30-35.

42. McIntyre B.S., et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Exp. Biol. Med. 224 (2000) 292-301.

43. Yu W, et al. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33 (1999) 26-32.

44. Yap S.P., et al. Pharmacokinetics and biovailability of alpha-, gamma- and delta-tocotrienols under different food status. J. Pharm. Pharmacol. 53 (2001) 67-71.

45. Qureshi A.A., et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (Palmvitee). Am. J. Clin. Nutr. 53 (1991) S1021-S1026.

46. Chow C.K.. Distribution of tocopherols in human plasma and red blood cells. Am. J. Nutr. 28 (1975) 756-760.

47. Wahlqvist M.L., et al. Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolaemic individuals without changes in coronary risk factors. Nutr. Res. 12 (Suppl 1) (1992) S181-S201.

48. Hayes K.C., et al. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols- observations in humans and hamsters. Proc. Soc. Exp. Biol. Med. 202 (1993) 353-359.

49. Ohrvall,M. et al. Tocopherol concentrations in adipose tissue. Relationships of tocopherol concentrations and fatty acid composition in serum in a reference population of Sedish men and women. Eur. J. Clin. Nutr. 48 (1994) 212-218.

50. Dimitrov N. V., et al. Some aspects of vitamin E related to humans and breast cancer prevention. Adv. Exp. Med. Biol. 364 (1994) 119-127.

51. Qureshi A. A., et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30 (1995) 1171-1177.

52. Tomeo A. C., et al. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30 (1995) 1179-1183.

53. Chen CL, et al. Hormone replacement therapy in relation to breast cancer. JAMA 2002 Feb 13;287(6):734-41.

54. Paolisso G, et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 2000 Jan;85(1):109-15.

55. Anderson JW, et al. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus. J Am Coll Nutr 1999 Oct;18(5):451-61.

56. Gazis A, et al. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 1999 Apr;16(4):304-11.

57. Davi G, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999 Jan 19;99(2):224-9.

58. Tutuncu NB, et al. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care 1998 Nov;21(11):1915-8.

59. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7(1-2):113-74.

60. Sokoloski JA, et al. Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: possible relationship to NF-kappaB. Leukemia 1997 Sep;11(9):1546-53.

61. Swain RA, et al. Therapeutic uses of vitamin E in prevention of atherosclerosis. Altern Med Rev 1999 Dec;4(6):414-23.

62. Wu D, et al. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 1999 Dec;147(2):297-307.

63. Davey PJ, et al. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study. Am J Cardiol 1998 Aug 15;82(4):414-7.

64. Copp RP, et al. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res 1999 Mar 20;822(1-2):80-7.

65. Tanyel MC, et al. Neurologic findings in vitamin E deficiency. Am Fam Physician 1997 Jan;55(1):197-201.

66. Arria AM, et al. Vitamin E deficiency and psychomotor dysfunction in adults with primary biliary cirrhosis. Am J Clin Nutr 1990 Aug;52(2):383-90.

67. Larsen PD, et al. Vitamin E deficiency associated with vision loss and bulbar weakness. Ann Neurol 1985 Dec;18(6):725-7.

68. Machlin LJ. Clinical uses of vitamin E. Acta Vitaminol Enzymol 1985;7 Suppl:33-43.

69. Elattar TM, et al. Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells. Anticancer Res 1999 Jan-Feb;19(1A):365-8.

70. Bairati I, et al. [Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers]. Bull Cancer Radiother 1996;83(1):12-6.